SNL BioSolutions ApS: Financial statements 2025
CVR: 44569272
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SNL BioSolutions ApS (CVR 44569272) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -606,994 and a net result of DKK -1,756,475 compared with DKK -3,896,480 the year before. Equity in the 2025 report amounted to DKK -4,706,639. The company had 3 employees in the financial year.
- Gross Profit
- DKK -606,994
- Profit/Loss
- DKK -1,756,475
- Equity
- DKK -4,706,639
- Total Assets
- DKK 671,421
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -607 t. | -1.8 mio. | -4.7 mio. | 3 |
| 2024 | - | -1.5 mio. | -3.9 mio. | -3.9 mio. | 6 |
Official annual report
How creditworthy is SNL BioSolutions ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of August 25, 2025, SNLB Holding ApS is registered as an owner of SNL BioSolutions ApS with an ownership share of 90%.
SNL BioSolutions ApS has published its annual report for 2024. Gross profit came to DKK -1,543,476, and the net result was DKK -3,896,480.
As of April 1, 2025, Jarne Elleholm has left the board of directors of SNL BioSolutions ApS.
About SNL BioSolutions ApS
SNL BioSolutions ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dayanand Suryabhan Jadhav. The board consists of Dayanand Suryabhan Jadhav. The company is owned by SNLB Holding ApS. According to the 2025 annual report, the company had an average of 3 employees. In 2025, the company reported a gross profit of DKK -606,994 and a net result of DKK -1,756,475 compared with DKK -3,896,480 the year before. Equity in the 2025 report amounted to DKK -4,706,639.